Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anar Mikailov

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Academy of Dermatology|February 10, 2019
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoidZachary Schwager, Anar Mikailov, Adam D Lipworth
JAMA Dermatology|December 31, 2015
Cost-effectiveness of Confirmatory Testing Before Treatment of OnychomycosisAnar Mikailov, Jeffrey Cohen, Cara Joyce, et al.
JAAD Case Reports|April 7, 2016
Leukocytoclastic vasculitis sparing a tattoo with halo effectChen Amy Chen, Anar Mikailov, Beverly Faulkner-Jones, et al.
JAAD Case Reports|April 7, 2016
Recurrent lobular capillary hemangiomas in a patient with neurofibromatosis type 1 (NF1) and von Hippel-Lindau syndrome (VHL)Karyn Haitz, Anar Mikailov, Ruth Foreman, et al.
Journal of Asthma and Allergy|January 25, 2013
Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysisAnar Mikailov, Ilona Kane, Stephen C Aronoff, et al.
Dermatology Research and Practice|July 31, 2018
Clinical Diagnostic Accuracy of Onychomycosis: A Multispecialty Comparison StudyDavid G Li, Jeffrey M Cohen, Anar Mikailov, et al.
Journal of the American Academy of Dermatology|May 12, 2020
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient diseaseColleen K Gabel, Emily Nguyen, Ryan Karmouta, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of the American Academy of Dermatology|February 10, 2019
Comment on "Oral diabetes medications other than dipeptidyl peptidase-4 inhibitors are not associated with bullous pemphigoid: A Finnish nationwide case-control study" and a case report of glucagon-like peptide-1 receptor agonist-induced bullous pemphigoidZachary Schwager, Anar Mikailov, Adam D Lipworth
JAMA Dermatology|December 31, 2015
Cost-effectiveness of Confirmatory Testing Before Treatment of OnychomycosisAnar Mikailov, Jeffrey Cohen, Cara Joyce, et al.
JAAD Case Reports|April 7, 2016
Leukocytoclastic vasculitis sparing a tattoo with halo effectChen Amy Chen, Anar Mikailov, Beverly Faulkner-Jones, et al.
JAAD Case Reports|April 7, 2016
Recurrent lobular capillary hemangiomas in a patient with neurofibromatosis type 1 (NF1) and von Hippel-Lindau syndrome (VHL)Karyn Haitz, Anar Mikailov, Ruth Foreman, et al.
Journal of Asthma and Allergy|January 25, 2013
Utility of adjunctive macrolide therapy in treatment of children with asthma: a systematic review and meta-analysisAnar Mikailov, Ilona Kane, Stephen C Aronoff, et al.
Dermatology Research and Practice|July 31, 2018
Clinical Diagnostic Accuracy of Onychomycosis: A Multispecialty Comparison StudyDavid G Li, Jeffrey M Cohen, Anar Mikailov, et al.
Journal of the American Academy of Dermatology|May 12, 2020
Use of teledermatology by dermatology hospitalists is effective in the diagnosis and management of inpatient diseaseColleen K Gabel, Emily Nguyen, Ryan Karmouta, et al.
Pageof 2